Loss of the Urothelial Differentiation Marker FOXA1 Is Associated with High Grade, Late Stage Bladder Cancer and Increased Tumor Proliferation

• David J. DeGraff ,

  * E-mail: david.degraff@vanderbilt.edu

  Affiliation Department of Urologic Surgery, Vanderbilt University Medical Center, Nashville, Tennessee, United States of America

  ⨯
• Peter E. Clark,

  Affiliation Department of Urologic Surgery, Vanderbilt University Medical Center, Nashville, Tennessee, United States of America

  ⨯
• Justin M. Cates,

  Affiliation Department of Pathology, Vanderbilt University Medical Center, Nashville, Tennessee, United States of America

  ⨯
• Hironobu Yamashita,

  Affiliation Department of Urologic Surgery, Vanderbilt University Medical Center, Nashville, Tennessee, United States of America

  ⨯
• Victoria L. Robinson,

  Affiliation Department of Surgery, University of Chicago, Chicago, Illinois, United States of America

  ⨯
• Xiuping Yu,

  Affiliation Department of Urologic Surgery, Vanderbilt University Medical Center, Nashville, Tennessee, United States of America

  ⨯
• Mark E. Smolkin,

  Affiliation Department of Public Health Sciences, University of Virginia, Charlottesville, Virginia, United States of America

  ⨯
• Sam S. Chang,

  Affiliation Department of Urologic Surgery, Vanderbilt University Medical Center, Nashville, Tennessee, United States of America

  ⨯
• Michael S. Cookson,

  Affiliation Department of Urologic Surgery, Vanderbilt University Medical Center, Nashville, Tennessee, United States of America

  ⨯
• Mary K. Herrick,

  Affiliation Department of Urologic Surgery, Vanderbilt University Medical Center, Nashville, Tennessee, United States of America

  ⨯
• Shahrokh F. Shariat,

  Affiliation Department of Urology, Weill Cornell Medical College, New York, New York, United States of America

  ⨯
• Gary D. Steinberg,

  Affiliation Department of Surgery, University of Chicago, Chicago, Illinois, United States of America

  ⨯
• Henry F. Frierson,

  Affiliation Department of Pathology, University of Virginia, Charlottesville, Virginia, United States of America

  ⨯
• Xue-Ru Wu,

  Affiliation Deparments of Urology and Pathology, New York University, New York, New York, United States of America

  ⨯
• Dan Theodorescu,

  Affiliation University of Colorado Comprehensive Cancer Center, Aurora, Colorado, United States of America

  ⨯
•  [ ... ],
• Robert J. Matusik

  Affiliations Department of Urologic Surgery, Vanderbilt University Medical Center, Nashville, Tennessee, United States of America, Department of Cancer Biology, Vanderbilt University Medical Center, Nashville, Tennessee, United States of America, Department of Cell and Developmental Biology, Vanderbilt University Medical Center, Nashville, Tennessee, United States of America

  ⨯
• [ view all ]
• [ view less ]